↓ Skip to main content

Long term outcome of high-risk neuroblastoma patients after immunotherapy with antibody ch14.18 or oral metronomic chemotherapy

Overview of attention for article published in BMC Cancer, January 2011
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source

Citations

dimensions_citation
112 Dimensions

Readers on

mendeley
89 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Long term outcome of high-risk neuroblastoma patients after immunotherapy with antibody ch14.18 or oral metronomic chemotherapy
Published in
BMC Cancer, January 2011
DOI 10.1186/1471-2407-11-21
Pubmed ID
Authors

Thorsten Simon, Barbara Hero, Andreas Faldum, Rupert Handgretinger, Martin Schrappe, Thomas Klingebiel, Frank Berthold

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 89 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 1%
Czechia 1 1%
Germany 1 1%
Italy 1 1%
Unknown 85 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 11 12%
Researcher 10 11%
Student > Master 9 10%
Other 8 9%
Student > Doctoral Student 8 9%
Other 24 27%
Unknown 19 21%
Readers by discipline Count As %
Medicine and Dentistry 40 45%
Agricultural and Biological Sciences 10 11%
Biochemistry, Genetics and Molecular Biology 6 7%
Immunology and Microbiology 5 6%
Unspecified 3 3%
Other 6 7%
Unknown 19 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 June 2023.
All research outputs
#7,503,741
of 22,925,760 outputs
Outputs from BMC Cancer
#2,078
of 8,333 outputs
Outputs of similar age
#55,524
of 182,992 outputs
Outputs of similar age from BMC Cancer
#14
of 38 outputs
Altmetric has tracked 22,925,760 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,333 research outputs from this source. They receive a mean Attention Score of 4.3. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 182,992 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 38 others from the same source and published within six weeks on either side of this one. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.